Emile E. Voest
Impact in
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.1%
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 152
- Colorectal Cancer Treatments and Studies 40
- Cancer Treatment and Pharmacology 35
- Cancer Cells and Metastasis 28
- Cancer Immunotherapy and Biomarkers 19
- Cancer Research 118
- Cancer Genomics and Diagnostics 53
- Cancer, Hypoxia, and Metabolism 45
- Co-authors
- Jeanine M.L. Roodhart (31 shared papers)Martijn F.B.G. Gebbink (27 shared papers)Alexander de Graeff (12 shared papers)Saskia Teunissen (11 shared papers)Krijn K. Dijkstra (10 shared papers)René H. Medema (8 shared papers)Rachel H. Giles (27 shared papers)Judah Folkman (3 shared papers)
- Journals
- Journal of Clinical Oncology (48 papers)Annals of Oncology (29 papers)Clinical Cancer Research (16 papers)British Journal of Cancer (11 papers)European Journal of Cancer (9 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Emile E. Voest
366 papers receiving 19.3k citations
Emile E. Voest's Hit Papers
Peers
Comparison fields: 5 of 170
- Cancer Research 4.2k
- Oncology 7.3k
- Molecular Biology 6.8k
- Hepatology 707
- Immunology 1.7k
Countries citing papers authored by Emile E. Voest
This map shows the geographic impact of Emile E. Voest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emile E. Voest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emile E. Voest more than expected).
Fields of papers citing papers by Emile E. Voest
This network shows the impact of papers produced by Emile E. Voest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emile E. Voest. The network helps show where Emile E. Voest may publish in the future.
Co-authors
The 25 scholars most cited alongside Emile E. Voest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 374 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer Hit paper breakdown → | 2009 | 1039 |
| 2 | Symptom Prevalence in Patients with Incurable Cancer: A Systematic Review Hit paper breakdown → | 2007 | 767 |
| 3 | Inhibition of Angiogenesis In Vivo by Interleukin 12 Hit paper breakdown → | 1995 | 657 |
| 4 | 2010 | 499 | |
| 5 | Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery Hit paper breakdown → | 2017 | 404 |
| 6 | 1996 | 389 | |
| 7 | Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers Hit paper breakdown → | 2018 | 383 |
| 8 | 2008 | 371 | |
| 9 | A model of angiogenesis in the mouse cornea. | 1996 | 371 |
| 10 | 2015 | 368 | |
| 11 | 2014 | 302 | |
| 12 | 2016 | 276 | |
| 13 | 2019 | 272 | |
| 14 | 2011 | 268 | |
| 15 | 2003 | 260 | |
| 16 | Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. | 1997 | 228 |
| 17 | Tumor organoids: Opportunities and challenges to guide precision medicine Hit paper breakdown → | 2021 | 224 |
| 18 | 2010 | 223 | |
| 19 | 2003 | 219 | |
| 20 | Delivering precision oncology to patients with cancer Hit paper breakdown → | 2022 | 216 |
About Emile E. Voest
Emile E. Voest is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 374 papers that have together received 19.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (53 papers), Angiogenesis and VEGF in Cancer (49 papers), Cancer, Hypoxia, and Metabolism (45 papers), Colorectal Cancer Treatments and Studies (40 papers), Cancer Treatment and Pharmacology (35 papers), Cancer Cells and Metastasis (28 papers), Lung Cancer Treatments and Mutations (21 papers) and Cancer Immunotherapy and Biomarkers (19 papers). The work is most often cited by research in Cancer Research (4.2k citations), Oncology (7.3k citations), Molecular Biology (6.8k citations), Hepatology (707 citations) and Immunology (1.7k citations). Emile E. Voest has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Jeanine M.L. Roodhart, Martijn F.B.G. Gebbink, Alexander de Graeff, Saskia Teunissen, Krijn K. Dijkstra, René H. Medema, Rachel H. Giles, Judah Folkman, Martijn P. Lolkema and Robert J. D’Amato. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, British Journal of Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.